Irini Xilouri

526 total citations
13 papers, 375 citations indexed

About

Irini Xilouri is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Irini Xilouri has authored 13 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Hematology and 4 papers in Genetics. Recurrent topics in Irini Xilouri's work include Multiple Myeloma Research and Treatments (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Acute Myeloid Leukemia Research (3 papers). Irini Xilouri is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers) and Acute Myeloid Leukemia Research (3 papers). Irini Xilouri collaborates with scholars based in Greece, Cyprus and United Kingdom. Irini Xilouri's co-authors include Meletios Α. Dimopoulos, Αchilles Anagnostopoulos, Dimitra Gika, Efstathios Kastritis, George Hamilos, Athanasios Zomas, Evangelos Terpos, Anna Tassidou, Eleni Efstathiou and Vassiliki Grigoraki and has published in prestigious journals such as Blood, Annals of Oncology and Haematologica.

In The Last Decade

Irini Xilouri

13 papers receiving 362 citations

Peers

Irini Xilouri
Stephen R. Zeldenrust United States
MQ Lacy United States
MA Gertz United States
M Hasib Sidiqi United States
Jeff Zonder United States
Miriam Hobbs United States
Stephen R. Zeldenrust United States
Irini Xilouri
Citations per year, relative to Irini Xilouri Irini Xilouri (= 1×) peers Stephen R. Zeldenrust

Countries citing papers authored by Irini Xilouri

Since Specialization
Citations

This map shows the geographic impact of Irini Xilouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irini Xilouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irini Xilouri more than expected).

Fields of papers citing papers by Irini Xilouri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irini Xilouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irini Xilouri. The network helps show where Irini Xilouri may publish in the future.

Co-authorship network of co-authors of Irini Xilouri

This figure shows the co-authorship network connecting the top 25 collaborators of Irini Xilouri. A scholar is included among the top collaborators of Irini Xilouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irini Xilouri. Irini Xilouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ierodiakonou, Despo, Eirini Vasarmidi, Maria Bolaki, et al.. (2021). Case Report: Diagnosis of Myelodysplastic Syndrome in a 72-Year-Old Female With Interstitial Lung Disease. Frontiers in Medicine. 8. 673573–673573. 1 indexed citations
2.
Koumaki, Dimitra, et al.. (2018). Ecthyma gangrenosum caused by Klebsiella pneumoniae and Streptococcus vestibularis in a patient with acute myeloid leukemia: an emerging pathogen. International Journal of Dermatology. 58(4). E83–E85. 5 indexed citations
3.
Kastritis, Efstathios, Αchilles Anagnostopoulos, Μαρία Ρούσσου, et al.. (2007). Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone. Haematologica. 92(10). 1351–1358. 125 indexed citations
4.
Kastritis, Efstathios, Athanasios K. Anagnostopoulos, Μαρία Ρούσσου, et al.. (2007). Treatment of Light Chain (AL) Amyloidosis and Light Chain Deposition Disease (LCDD) with the Combination of Bortezomib and Dexamethasone.. Blood. 110(11). 191–191. 1 indexed citations
5.
Kastritis, Efstathios, Evangelos Terpos, Αchilles Anagnostopoulos, Irini Xilouri, & Meletios Α. Dimopoulos. (2006). Angiogenetic Factors and Biochemical Markers of Bone Metabolism in POEMS Syndrome Treated with High-Dose Therapy and Autologous Stem Cell Support. Clinical Lymphoma & Myeloma. 7(1). 73–76. 17 indexed citations
6.
Viniou, Nora, T. P. Vassilakopoulos, Maria Dimopoulou, et al.. (2006). FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: a pilot study.. PubMed. 26(2A). 1201–7. 6 indexed citations
7.
Mantadakis, Elpis, et al.. (2006). Transient loss of the Y-chromosome in an elderly man with anemia and lead poisoning: chance occurrence or a clonal marker of the underlying hematological abnormality?. PubMed. 91(8 Suppl). ECR37–ECR37. 2 indexed citations
8.
Mantadakis, Elpis, et al.. (2005). Veno‐occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine. American Journal of Hematology. 79(3). 216–219. 5 indexed citations
9.
Mantadakis, Elpis, et al.. (2005). Agnogenic myeloid metaplasia with pulmonary hematopoiesis. Hematology. 10(6). 501–503. 4 indexed citations
10.
Dimopoulos, Meletios Α., George Hamilos, Athanasios Zomas, et al.. (2004). Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma. The Hematology Journal. 5(2). 112–117. 105 indexed citations
11.
Alexandrakis, Michael G., Freda Passam, Emmanuel S. Ganotakis, et al.. (2003). The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma. Clinical & Laboratory Haematology. 25(1). 41–46. 59 indexed citations
12.
Dimopoulos, Meletios Α., George Hamilos, Konstantinos Zervas, et al.. (2003). Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia. Annals of Oncology. 14(8). 1299–1305. 36 indexed citations
13.
Dimopoulos, Meletios Α., Panayiotis Panayiotidis, Vassiliki Grigoraki, et al.. (2001). Oral hyperfractionated cyclophosphamide and intermittent thalidomide-dexamethasone for previously treated patients with multiple myeloma. 1. 16416. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026